Cara Therapeutics Inc. sell StockNews.com
Start price
22.06.24
/
50%
€0.30
Target price
22.06.25
-
Performance (%)
24.31%
End price
23.06.25
-
Summary
This prediction is currently being closed. The prediction currently has a disappointing performance of 24.31%. StockNews_com has a follow-up prediction for Cara Therapeutics Inc. where he still thinks Cara Therapeutics Inc. is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cara Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 3.109% | -0.124% | 36.052% |
| iShares Nasdaq 100 | 3.088% | 4.723% | 20.631% |
| iShares Nikkei 225® | 4.760% | 5.051% | 11.016% |
| iShares S&P 500 | 1.840% | 3.430% | 13.790% |
Comments by StockNews_com for this prediction
In the thread Cara Therapeutics Inc. diskutieren
Cara Therapeutics, Inc. (NASDAQ: CARA) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CARA provided by MarketBeat
In the thread Trading Cara Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Cara Therapeutics Inc.
Stopped prediction by StockNews_com for Cara Therapeutics Inc.
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
17.02.24
17.02.24
-
17.02.25
17.02.25
-25.51%
18.02.25
18.02.25
